Charité – Universitätsmedizin Berlin (Cluster of Excellence ImmunoPreCept, with the Max Delbrück Center) is recruiting a W2 professor to lead an independent research group on predicting and identifying molecular determinants of health-disease transitions — immune-tissue/immune-stem cell interactions, immunometabolism, neuro-immune interactions — using single-cell omics and AI-driven computational methods, with access to longitudinal patient cohorts. Fixed-term 5-year position, potentially extendable.
Requires a PhD and/or MD plus postdoctoral qualification or equivalent achievement in immunology/biomedical research.
Text as published by the employer. Always confirm details on the employer's site.